等待开盘 09-17 09:30:00 美东时间
0.000
NaN.00%
Collegium Pharmaceutical, Inc. will present nine posters at PAINWeek 2025, highlighting real-world data from its pain portfolio, including BELBUCA and XTAMPZA ER. The posters aim to provide insights for healthcare professionals and reflect the company's commitment to responsible pain management. The session will take place on September 4, 2025, in Las Vegas.
08-25 12:00
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. A live conference call and webcast will be held at 8:00 a.m. ET. Investors can join via phone at (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference "Collegium Pharmaceutical Q2 2025 Earnings Call." The webcast will be available on the Company’s website at www.collegium...
07-24 12:00
Collegium Pharmaceutical, Inc. announced a new $150 million stock repurchase program through December 31, 2026, replacing a previous program that expired with $65 million remaining. The company has returned $222 million to shareholders since 2021 and currently has 32.1 million shares outstanding.
07-07 12:00